-
iNCOVACC (codenamed BBV154) is an
intranasal COVID-19
vaccine candidate developed by
Bharat Biotech,
American company Precision Virologics and the Washington...
- the PLA
Academy of
Military Science. Full (0)
Emergency (1)
Indonesia iNCOVACC, also
called BBV154 is an
adenovirus vector vaccine developed by Bharat...
- 2022,
India and
China approved the two
first nasal COVID‑19
vaccines (
iNCOVACC and Convidecia),
which may (as boosters) also
reduce transmission (potentially...
- Covaxin, a whole-inactivated-virus-based
vaccine delivered by
injection iNCOVACC, an
adenovirus vectored intranasal COVID-19
vaccine This disambiguation...
- AdCLD-CoV19
BriLife COH04S1 DelNS1-2019-nCoV-RBD-OPT GRAd-COV2
ImmunityBio iNCOVACC INNA-051 NDV-HXP-S
Vaxart COVID-19
vaccine Virus-like
particles ABNCoV2...
-
royalty from
Covaxin sale
INCOVACC COVID-19 (Virus SARS-CoV-2)
Bharat Biotech/Indian
Council of
Medical Research Completed iNCOVACC (codenamed BBV154) is...
-
vaccines have been
developed with the
onset of the COVID-19 pandemic.
inCOVACC, Razi Cov Pars, Sputnik, and
Convidicia are
nasal COVID-19
vaccines that...
-
Sputnik Light,
Sputnik V, Oxford–AstraZeneca, Convidecia, Janssen, and
iNCOVACC sixteen subunit vaccines: Abdala, Corbevax, COVAX-19, EpiVacCorona, IndoVac...
- (15+),
Corbevax (12-14),
Sputnik V (18+),Corbevax (12-14),
Gemcovac (18+)
Incovacc (18+), ZyCoV-D (18+) and
Covovax (12+). In the ****ure, the
Health ministry...
